We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

41 hedge funds and large institutions have $158M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 2

362% more capital invested

Capital invested by funds: $34.1M → $158M (+$124M)

286% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 7

129% more call options, than puts

Call options by funds: $2.03M | Put options by funds: $888K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

95% more funds holding

Funds holding: 21 → 41 (+20)

Holders
41
Holders Change
+20
Holders Change %
+95.24%
% of All Funds
1.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
27
Increased
11
Reduced
2
Closed
7
Calls
$2.03M
Puts
$888K
Net Calls
+$1.14M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$30M
2
SCM
Scopia Capital Management
New York
+$27.6M
3
ACA
Avoro Capital Advisors
New York
+$15M
4
GC
GMT Capital
Georgia
+$11.6M
5
RCM
RA Capital Management
Massachusetts
+$8.72M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$11.5M
2
PVI
Pura Vida Investments
New York
-$1.01M
3
OM
Opaleye Management
Massachusetts
-$399K
4
OC
Oppenheimer & Co
New York
-$287K
5
Goldman Sachs
Goldman Sachs
New York
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
26
HighTower Advisors
Illinois
$269K +$61.5K +3,000 +30%
SM
27
Sabby Management
Florida
$257K +$255K +12,416 New
CI
28
Cowen Inc
New York
$209K +$207K +10,100 New
Ohio Public Employees Retirement System (OPERS)
29
Ohio Public Employees Retirement System (OPERS)
Ohio
$207K +$205K +9,991 New
VanEck Associates
30
VanEck Associates
New York
$148K +$147K +7,158 New
Bank of America
31
Bank of America
North Carolina
$141K +$130K +6,325 +1,265%
UBS Group
32
UBS Group
Switzerland
$33K +$6.3K +307 +24%
EDRE
33
Edmond de Rothschild (Europe)
Luxembourg
$17K +$16.4K +800 New
EDRH
34
Edmond de Rothschild Holding
Switzerland
$17K +$16.4K +800 New
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$14K -$13.7K -668 -49%
TRCT
36
Tower Research Capital (TRC)
New York
$12K +$11.9K +581 New
MFS
37
MSI Financial Services
Massachusetts
$12K +$12.3K +600 New
EWM
38
Edge Wealth Management
New York
$10K – – –
AA
39
ALPS Advisors
Colorado
$6.96K +$345K +16,814 +100%
Wells Fargo
40
Wells Fargo
California
$4K +$4.21K +205 New
Adage Capital Partners
41
Adage Capital Partners
Massachusetts
– -$11.5M -750,000 Closed
PVI
42
Pura Vida Investments
New York
– -$1.01M -53,000 Closed
OM
43
Opaleye Management
Massachusetts
– -$399K -26,000 Closed
OC
44
Oppenheimer & Co
New York
– -$287K -18,708 Closed
Goldman Sachs
45
Goldman Sachs
New York
– -$277K -18,051 Closed
US Bancorp
46
US Bancorp
Minnesota
– -$15K -1,000 Closed
Deutsche Bank
47
Deutsche Bank
Germany
– -$4K -300 Closed
Citigroup
48
Citigroup
New York
– -$3K -146 -97%
1
2

NDRM Hedge Fund Activity: Q3 2015 in Review

41 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2015, worth a combined $158M — up 362% from $34.1M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new NDRM positions and 7 closed out — a net gain of 20 holders — while 11 added to existing stakes and 2 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $30M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $11.5M sold.

  • 41 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2015, up from 21 in Q2 2015.
  • Funds reported $158M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2015, up 362% quarter-over-quarter.
  • 27 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2015 and 7 closed out, a net change of +20 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2015 was Redmile Group, an estimated $30M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2015 was Adage Capital Partners, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2015.